REG - Eco Animal Health Gp - Board Change

ECO Animal HealthAnnouncement

Tue 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260331:nRSe6987Ya&default-theme=true

RNS Number : 6987Y  Eco Animal Health Group PLC  31 March 2026

ECO Animal Health Group plc

("ECO" or the "Company")

 

Board Change

 

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health
company with a portfolio of marketed veterinary products and a maturing
proprietary R&D pipeline, announces that Frank Armstrong has informed the
Board of his intention to step down from his role as Independent Non-Executive
Director of the Company, effective following the conclusion of this year's
Annual General Meeting (AGM).

 

Dr Armstrong, who also serves as Chair of the Remuneration Committee, was
recently elected as the Senior Lay Member (Chair) of the Court (Board) of the
University of Edinburgh, a role he will assume in August 2026. Given the
duties associated with this role and length of his tenure at ECO, Dr Armstrong
has decided to retire from his position and will step down at the AGM, which
is currently anticipated to be held in September.

 

The Board has commenced a thorough search process to identify a suitable
replacement. Further updates will be provided in due course.

 

Dr Joachim Hasenmaier, Chairman of ECO Animal Health, commented: "On behalf of
the Board, I would like to thank Frank for his invaluable contributions to ECO
during his tenure as Independent Non-Executive Director and in his role as
Chair of the Remuneration Committee. His counsel and expertise have been
instrumental in supporting the Company through a significant period of growth.
We wish him every success in his new role."

 

-Ends-

Contacts

                                                                020 8447 8899

 ECO Animal Health Group plc

 David Hallas (Chief Executive Officer)

 Christopher Wilks (Chief Financial Officer)

 ICR Healthcare (Financial PR)                                  020 3709 5700

 Mary-Jane Elliott

 Jessica Hodgson

 Singer Capital Markets (Nominated Adviser & Joint Broker)      020 7496 3000

 Philip Davies

 Jalini Kalaravy

 Samed Ethemi

 Panmure Liberum (Joint Broker)                                 020 3100 2000

 Emma Earl

 Will Goode

 Mark Rogers

 Rupert Dearden

 Equity Development                                             020 7065 2692

 Hannah Crowe

 Matt Evans

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing
branded veterinary pharmaceuticals globally, with expertise in antibiotics and
vaccines for pigs and poultry. We have a maturing proprietary R&D
pipeline.

Headquartered in the UK, with global offices including R&D and
manufacturing, we have marketing authorisations in over 70 countries and
employ over 200 people worldwide.

Our lead product, Aivlosin(®) is a proprietary, patented medication which is
effective against both respiratory and intestinal diseases in pigs and
poultry.

Click here for more information: https://ecoanimalhealth.com
(https://ecoanimalhealth.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOASDLFMSEMSEED



            Copyright 2019 Regulatory News Service, all rights reserved